MedTech Featured Stories

Bristol subpoenaed over foreign sales practices

4/26/2012

U.S. drugmaker Bristol-Myers Squibb Co said on Thursday that it received a subpoena from securities regulators regarding its sales and marketing practices in various foreign countries.

Bristol-Myers, in a filing, said it received the subpoena from the U.S. Securities and Exchange Commission (SEC) last month in connection with an investigation under the Foreign Corrupt Practices Act (FCPA).
 

Reuters



Return to Previous Page

Today Is:
Thursday, October 23, 2014


October Events

<< >>
SMTWTFS
1234
567891011
12131415161718
19202122232425
262728293031